Skip to main content
Premium Trial:

Request an Annual Quote

TessArae, Kindstar Developing Genetic Tests for Chinese Population

NEW YORK (GenomeWeb News) – TessArae and Kindstar Global today announced a collaboration to develop genetic tests for the Chinese population.

The two firms provided no details about the test that would be developed except that they will be pan-ethnic screens for the Chinese population and use TessArae's targeted sequencing development platform and bioanalysis software. The tests will run in Kindstar's laboratories in China.

TessArae's platform combines a multiplexed amplification strategy with an Affymetrix microarray protocol. Results are analyzed by the Potomac Fall, Va.-based company's GeneCipher algorithms.

Kindstar is the largest esoteric reference laboratory in China, TessArae said, providing its services to more than 3,300 hospitals. Last week, it and Illumina said they were collaborating to introduce molecular assays based on Illumina products in Kindstar's laboratories.

TessArae and Kindstar did not disclose the financial terms of their deal.